This session addresses how multimodal monitoring can be used to modify treatment for deteriorating patients before irreversible injury sets in.
Learning Outcome: After completing this learning activity, the participant will be able to discuss specific ways in which multimodal monitoring can be used to modify treatment for deteriorating patients before irreversible injury sets in.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 10/2/24.
Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online nursing continuing professional development (NCPD) evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):
Planning Committee Disclosures: There are no Planning Committee disclosures to declare.
Speaker Disclosures: Carla Jungquist, PhD, ANP-BC, FAAN, discloses that she served as the primary investigator of the Prodigy Medtronic-funded study and receives salary support from Medtronic.
There are no other speaker disclosures to declare.
Commercial Support: This presentation was sponsored by Medtronic.
No other commercial support declared.
Accreditation Statement: This session is jointly provided by Anthony J. Jannetti, Inc. (AJJ) and the Academy of Medical-Surgical Nurses (AMSN).
Anthony J Jannetti, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
Anthony J. Jannetti, Inc. is a provider approved by the California Board of Registered Nursing, Provider Number CEP5387.
PhD, ANP-BC, FAAN,
University of Buffalo, School of Nursing